PulmoSal (sodium chloride) Disease Interactions
There is 1 disease interaction with PulmoSal (sodium chloride):
Sodium Salts (Includes PulmoSal) ↔ Sodium/Water Imbalance
Severe Potential Hazard, High plausibility
Applies to: Fluid Retention, Congestive Heart Failure, Hypokalemia
Sodium chloride can induce sodium and water retention and result in hypernatremia, hypokalemia, edema and aggravation of congestive heart failure. Therapy with sodium- containing agents should be administered with extreme caution, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states where there is edema with sodium retention. Clinical monitoring of acid/base balance and electrolytes prior to, during, a following completion of therapy with sodium- containing agents is recommended.
- "Product Information. Megace (megestrol)." Bristol-Myers Squibb, Princeton, NJ.
- "Product Information. Calcibind (cellulose sodium phosphate)." Mission Pharmaceutical Company, San Antonio, TX.
- "Product Information. Sodium Benzoate (sodium benzoate)." Taylor Pharmaceuticals, San Clemente, CA.
PulmoSal (sodium chloride) drug Interactions
There are 2 drug interactions with PulmoSal (sodium chloride)
More about PulmoSal (sodium chloride)
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.